Varex Imaging Corporation (VREX) Q2 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call showed strong financial performance with a 5% revenue increase and improved gross margins. EPS also grew to $0.50, indicating robust profitability. The medical imaging segment's demand supports future growth. Although operating expenses rose, they were tied to R&D investments, which could drive innovation. No strategic initiatives or risks were discussed, leaving a neutral impact. Overall, the financial results and EPS improvement suggest a positive stock price movement.
Key Financial Performance
Revenue Revenue for Q2 2026 was $210 million, representing a 5% increase year-over-year. The growth was driven by strong demand in the medical imaging segment.
Gross Margin Gross margin improved to 42% in Q2 2026, up from 40% in Q2 2025. This improvement was attributed to better product mix and operational efficiencies.
Operating Expenses Operating expenses were $60 million in Q2 2026, a 3% increase compared to Q2 2025. The rise was due to higher R&D investments.
Net Income Net income for Q2 2026 was $25 million, up 8% year-over-year. This increase was primarily due to higher revenue and improved gross margins.
Earnings Per Share (EPS) Earnings per share for Q2 2026 were $0.50, an increase from $0.46 in Q2 2025, reflecting the growth in net income.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Accounting Officer
Belfiore Director
CEO Director
CFO Principal
Director Shubham
Division PM
EDT Lawrence
Inc Greetings
Jefferies LLC
LLC Research
LLC Young
Lawrence Solow
Li Jefferies
Maheshwari CFO
Officer Sidoti
PM EDT
Principal Accounting
Relations President
Relations statement
Research Division
Securities Inc
Shubham Maheshwari
Sidoti LLC
Varex pleasure
Young Li
pleasure Director
VREX Transcript
Varex Imaging Corporation (VREX) Q2 2026 Earnings Call Transcript
Positive5-7
The earnings call showed strong financial performance with a 5% revenue increase and improved gross margins. EPS also grew to $0.50, indicating robust profitability. The medical imaging segment's demand supports future growth. Although operating expenses rose, they were tied to R&D investments, which could drive innovation. No strategic initiatives or risks were discussed, leaving a neutral impact. Overall, the financial results and EPS improvement suggest a positive stock price movement.
Varex Imaging Corporation (VREX) Q1 2026 Earnings Call Transcript
Positive2-11
The earnings call summary reveals strong financial performance with increased operating income and adjusted EBITDA. The Q&A section highlights optimism in the market outlook and potential double-digit growth in the Industrial segment. The India expansion and photon counting technology are promising, despite some inventory challenges. The cautious EPS guidance is offset by strong CT adoption and customer engagement. Overall, the sentiment is positive, likely resulting in a 2% to 8% stock price increase.
Varex Imaging Corporation (VREX) Q4 2025 Earnings Call Transcript
Unknown11-18
The earnings call presents a mixed picture: strong financial performance with record high revenue and improved profitability, but concerns about cash reduction and uncertain guidance. The Q&A indicates solid demand and growth prospects, but management's lack of specific guidance and avoidance of details raises uncertainty. Without clear guidance, the market may react cautiously, resulting in a neutral stock price movement.
Varex Imaging Corporation (VREX) Q3 2025 Earnings Call Transcript
Unknown8-8
The earnings call summary presents a mixed picture. Financial performance is stable with strong cash management and expected revenue growth, but gross margins are impacted by tariffs. Product development in photon counting is promising but lacks immediate commercialization. Market strategy shows steady demand in China and a strong cargo systems pipeline, but lacks clarity in future guidance. Shareholder returns and debt repayment plans are positive, yet overall, the lack of clear guidance and tariff impacts balance the sentiment to neutral.
VREX Slides
VREX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
